Sotaro Miwa

The Bisphosphonate YM529 Inhibits Osteolytic and Osteoblastic Changes and CXCR-4–Induced Invasion in Prostate Cancer

Sotaro Miwa, Atsushi Mizokami, Evan T. Keller et al. · Cancer Research · 2005 · 73 citations · Full text

Medicine, Oncology, Pharmacology +14

Exogenous SPARC Suppresses Proliferation and Migration of Prostate Cancer by Interacting With Integrin β1

Min‐Kyoung Shin, Atsushi Mizokami, Jungim Kim et al. · The Prostate · 2013 · 48 citations · Full text

Medicine, Molecular Biology, Oncology +14

Cardiovascular and respiratory effects of the degree of head‐down angle during robot‐assisted laparoscopic radical prostatectomy

Yoshifumi Kadono, Hiroshi Yaegashi, Kazuaki Machioka et al. · International Journal of Medical Robotics and Computer Assisted Surgery · 2013 · 38 citations · Full text

Medicine, Perioperative Medicine, Surgery +16

Risedronate Recovers Bone Loss in Patients With Prostate Cancer Undergoing Androgen-deprivation Therapy

Kouji Izumi, Atsushi Mizokami, Kazuhiro Sugimoto et al. · Urology · 2009 · 31 citations

Medicine, Oncology, Surgery +13

Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal‐related events in patients with prostate cancer with bone metastasis

Kouji Izumi, Atsushi Mizokami, Shingo Itai et al. · British Journal of Urology · 2011 · 28 citations · Full text

Medicine, Oncology, Urology +13